PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,220.00
-75.00 (-1.75%)
Last updated: Jan 8, 2026, 11:28 AM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 92.14 billion as of January 8, 2026. Its market cap has increased by 25.29% in one year.
Market Cap
92.14B
Enterprise Value
97.49B
Revenue
171.66B
Ranking
n/a
PE Ratio
782.53
Stock Price
4,220.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 92.14B, an increase of 745.97%. That is a compound annual growth rate of 7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 92.14B | 1.20% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |